Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

HDAC inhibitor active against multiple myeloma in vitro and in animal model

Dec. 11, 2002

Antitumor activity of Geron's telomerase inhibitor reported in presentation at ASH meeting

Dec. 11, 2002

New proline-based MMP inhibitors in early development at Aventis

Dec. 11, 2002

New proapoptotic compounds identified at Cell Pathways

Dec. 11, 2002

Inhibitors of CDK2, CDK5 and/or GSK-3 covered by Pfizer patent

Dec. 11, 2002

Patent for p53/taxane combination therapy awarded to Aventis, licensed to Introgen

Dec. 11, 2002

Epimmune files IND for cancer vaccine

Dec. 10, 2002

Millennium to submit Velcade NDA and MAA filings by early 2003

Dec. 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...